authors
- Shankar, Lalitha K
- Hoffman, John M
- Bacharach, Steve
- Graham, Michael M
- Karp, Joel
- Lammertsma, Adriaan A
- Larson, Steven Mark
- Mankoff, David A
- Siegel, Barry A
- Van den Abbeele, Annick
- Yap, Jeffrey
- Sullivan, Daniel
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.
Conference Paper
Overview
publication date
- June 1, 2006
published in
Research
keywords
- Clinical Trials as Topic
- Fluorodeoxyglucose F18
- Neoplasms
- Outcome Assessment, Health Care
- Positron-Emission Tomography
Identity
Scopus Document Identifier
- 33746036112
PubMed ID
- 16741317
Additional Document Info
has global citation frequency
volume
- 47
issue
- 6